Product Images Cyclobenzaprine Hydrochloride
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Cyclobenzaprine Hydrochloride NDC 68788-8596 by Preferred Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Image - 7d5e3bad 7f85 4e2b 81c5 7981c456e45f 01
IMAGE - 7d5e3bad 7f85 4e2b 81c5 7981c456e45f 02
This text seems to list the side effects and percentages of patients experiencing them when taking Cyclobenzaprine HCI tablets in 5mg and 10mg doses. It also includes the percentages for patients on a placebo. The side effects listed include drowsiness, dry mouth, fatigue, and headache. The data provided are categorized by the number of patients (N) and the percentages. It appears to be a comparison of the effects of different doses of Cyclobenzaprine HCI tablets and a placebo.*
IMAGE - 7d5e3bad 7f85 4e2b 81c5 7981c456e45f 03
This text provides data from clinical studies and a surveillance program on the side effects associated with Cyclobenzaprine HCI Tablets, 10 mg. The most common side effects reported were drowsiness (39%), dry mouth (2%), and dizziness (1%) in the clinical studies. In the surveillance program, the side effects reported were drowsiness (16%), dry mouth (7%), and an unknown side effect at 3%. These percentages represent the prevalence of these side effects among patients taking this medication.*
Cyclobenzaprine HCl Tablets USP 10mg - Cyclobenzaprine 5 mg
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
